JHOP - December 2020 Vol 10, No 6
These abstracts represent the balance of studies featured during the poster presentation at the 16th Annual Conference of the Hematology/Oncology Pharmacy Association (HOPA) in April 2020
in Tampa, FL. The other abstracts were previously published in the June, August, and October issues of the journal.
This section provides a brief overview of new cancer drugs or new indications approved
by the FDA between September 1, 2020, and December 1, 2020.
Results 1 - 7 of 7